Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Cancer
|
August 3, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study
Mohammed M Milhem, Yousef Zakharia, Diwakar Davar, et al.
The New England Journal of Medicine
|
August 23, 2018
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Hussein A Tawbi, Peter A Forsyth, Alain Algazi, et al.
The Lancet. Oncology
|
January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
NPJ Precision Oncology
|
November 14, 2023
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
Gino K In, Jennifer R Ribeiro, Jun Yin, et al.
Pigment Cell & Melanoma Research
|
February 4, 2019
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities
Zeynep Eroglu, Sheri L Holmen, Qing Chen, et al.
Nature Reviews. Clinical Oncology
|
August 29, 2013
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L Kaufman, John M Kirkwood, F Stephen Hodi, et al.
The Lancet. Oncology
|
September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
The Lancet. Oncology
|
June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO group
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2019
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Paul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 12, 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
Susan M Swetter, John A Thompson, Mark R Albertini, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Cancer
|
August 3, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study
Mohammed M Milhem, Yousef Zakharia, Diwakar Davar, et al.
The New England Journal of Medicine
|
August 23, 2018
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Hussein A Tawbi, Peter A Forsyth, Alain Algazi, et al.
The Lancet. Oncology
|
January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
NPJ Precision Oncology
|
November 14, 2023
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
Gino K In, Jennifer R Ribeiro, Jun Yin, et al.
Pigment Cell & Melanoma Research
|
February 4, 2019
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities
Zeynep Eroglu, Sheri L Holmen, Qing Chen, et al.
Nature Reviews. Clinical Oncology
|
August 29, 2013
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L Kaufman, John M Kirkwood, F Stephen Hodi, et al.
The Lancet. Oncology
|
September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
The Lancet. Oncology
|
June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO group
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2019
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Paul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 12, 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
Susan M Swetter, John A Thompson, Mark R Albertini, et al.
Page
of 10